HOPE-3 trial suggests that statin therapy is beneficial even in low-risk populations
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Daniel Gaudet, MD, PhD
Pam R. Taub, MD, FACC, FASPC
Daniel Gaudet, MD, PhD
Pam R. Taub, MD, FACC, FASPC
Kausik Ray, MBChB, MD, MPhil
Daniel Gaudet, MD, PhD
Børge G. Nordestgaard, MD, DMSc
Pam R. Taub, MD, FACC, FASPC
Kausik Ray, MBChB, MD, MPhil
